ING2 (inhibitor of growth 2) is a candidate tumorsuppressor gene involved in cell cycle control, apoptosis and senescence. Although the functions of ING2 within the chromatin remodeling complex Sin3A/histone deacetylase (HDAC) and in the p53 pathway have been described, how ING2 itself is regulated remains unknown. In this study we report for the first time that ING2 can be sumoylated by small ubiquitin-like modifier 1 (SUMO1) on lysine 195 both in vitro and in vivo. Strikingly, ING2 sumoylation enhances its association with Sin3a. We provide evidences that ING2 can bind to the promoter of genes to mediate their expression and that sumoylation of ING2 is required for this binding to some of these genes. Among them, we identified the gene TMEM71 (transmembrane protein 71), whose expression is regulated by ING2 sumoylation. ING2 must be sumoylated to bind to the promoter of TMEM71 and to recruit the Sin3A chromatin-modifying complex to this promoter, in order to regulate TMEM71 transcription. Hence, sumoylation of ING2 enhances its binding to the Sin3A/HDAC complex and is required to regulate gene transcriptions.
Introduction
ING2 is a member of the ING (INhibitor of Growth) candidate tumor-suppressor gene family. The founding member of the family, ING1, was initially discovered by a screen designed to identify genes that allow neoplastic transformation when repressed (Garkavtsev et al., 1996) . Subsequently, four other members of the family, ING2-ING5, were identified by a homology search (Nagashima et al., 2001 Shiseki et al., 2003) . INGs are nuclear proteins and one important structural feature of these proteins is the presence of a highly conserved plant homeodomain zinc-finger in their C-terminal part. Such domains are commonly found in proteins involved in modifying chromatin (Bienz, 2006; Mellor, 2006) . Accordingly, all ING proteins have been described as being associated with either histone acetyltransferase or histone deacetylase (HDAC) complexes that implicate them in chromatin remodeling (Doyon et al., 2006) .
ING2 has been described as a stable component of the HDAC complex Sin3A/HDAC1/2 and also interacts with the acetyltransferase protein p300 (Pedeux et al., 2005; Doyon et al., 2006) . Subsequently, the plant homeodomain of ING2 was shown to have a high affinity for the histone 3 tri-methylated on the lysine 4. The interaction between ING2 and this modified histone allows the stabilization of the Sin3A/HDAC complex onto the promoter of the proliferative genes c-myc and cyclin D1 to mediate their repression (Shi et al., 2006) . Initially, ING2 was reported to enhance p53 acetylation to negatively regulate cell growth, to induce apoptosis and to regulate the onset of replicative senescence (Nagashima et al., 2001; Pedeux et al., 2005) . In these pathways, it has been reported that the lipid signaling molecule phosphatidylinositol-5-phosphate binds and activates ING2 (Gozani et al., 2003) . Recently, it was reported that ING2 could mediate transforming growth factor-b-dependent responses (Sarker et al., 2008) . Altogether, these studies indicate that ING2 may have tumor-suppressor functions. Accordingly, ING2 is frequently lost in human tumors (Ythier et al., 2008) . Indeed, ING2 locus is deleted in the head and neck squamous cell carcinomas (Borkosky et al., 2009) . In melanoma and in hepatocellular carcinoma a loss of ING2 nuclear expression has been observed (Lu et al., 2006; Zhang et al., 2008) . Moreover, we have recently shown a strong decrease of ING2 expression, both at the protein and the mRNA level, in a large proportion of non-small cell lung carcinoma .
Sumoylation is a reaction in which the small ubiquitin-like modifier (SUMO), a polypeptide of 11kDa, is covalently linked to a variety of proteins. Similarly to ubiquitination, sumoylation is achieved by activating E1, conjugating E2 and ligating E3 enzymes. In contrast to ubiquitination, sumoylation has been implicated in various cellular processes such as the regulation of protein subcellular localization, protein stabilization by competition with ubiquitination, protein-protein interaction and transcription factor activity (Hay, 2005) . Many studies have reported the sumoylation of transcription factors (for example, Sp3, Smad4, Elk-1 and so on) and most of the time, it was associated with transcriptional repression (Gill, 2005) . However, in a limited number of cases, sumoylation was reported to increase transcriptional activity of proteins such as the HSF1 (heat shock factor 1) or the NFAT-1 (nuclear factor of activated T cells) (Hong et al., 2001; Terui et al., 2004) .
Although the functions of INGs in cellular processes have received much attention, how ING2 itself may be regulated remains poorly understood. In this study, we report that ING2 can be sumoylated by SUMO1 and that sumoylation enhances ING2 association with Sin3A. We also show that the transcriptional regulation of several genes requires ING2, among which some of them are also dependent on ING2 sumoylation. Moreover, detailed analysis of one of these genes shows that the sumoylation of ING2 is required for the presence of both ING2 and Sin3A on its promoter to allow its expression. Thus, we identified for the first time a mechanism of ING2 regulation by a post-translational modification.
Results
ING2 is sumoylated by SUMO1 in vitro and in vivo ING2 was previously described as a component of the Sin3A/HDAC1/2 complex. Indeed, ING2 and a second band approximately 10 kDa higher are detected in mSin3a immunoprecipitation (Figure 1a) . Importantly, the level of Sin3a expression was not affected by ING2 downregulation (Figure 1a and Supplementary Figure  1) . The reduced intensity of slow-migrating band in cells transfected with a small interfering RNA (siRNA) targeting ING2 indicates that it is specific to ING2 and therefore it may be a post-translationally modified form of ING2. Consequently, we hypothesized that the higher band could be a sumoylated ING2 protein. in vitro sumoylation experiments show that glutathione S-transferase-ING2 can be sumoylated twice by SUMO1. Unlike ubiquitin, SUMO1 does not form chains (Hay, 2005) . We thus concluded that ING2 can be sumoylated on two residues in vitro (Figure 1b) . In U2OS cells, co-transfection of ING2 and SUMO1 fused to a histidine tag (His-SUMO1) followed by a histidine purification results in the detection of two ING2 sumoylated forms (Figure 1c ). Taken together, these results indicate that ING2 can be sumoylated by SUMO1 both in vitro and in vivo.
ING2 is sumoylated by SUMO1 on lysine 195
To determine which region of the ING2 protein is sumoylated, we generated ING2 mutants truncated in their amino (N) or carboxy (C) terminal part (ING2-DC165, ING2-DC204 and ING2-DN240; Figure 2a ). The ING2-truncated mutants were co-transfected with His-SUMO1 and the resulting protein extracts were subjected to histidine purification (Figure 2b) (Figure 2b ). On the contrary, ING2-DC165 shows a weak sumoylation signal and only one sumoylated form (Figure 2b ). This result indicates that the predominantly sumoylated lysine residue of ING2 may be located between the residues 165 and 204. Lysines subjected to sumoylation are commonly found in a sumoylation consensus motif, cKxE (where c is a hydrophobic residue, K the sumoylated lysine, x is any residue and E a glutamic acid) (Rodriguez et al., 2001) .
Bioinformatic analysis of the amino acid sequence of ING2 using the SumoPlot software (http://www.abgent. com.cn/doc/sumoplot/sendmail.asp) revealed the presence of three potential consensus sites for sumoylation ( Figure 2a ). To identify the sumoylated lysine residues, we generated ING2 mutants in which the lysine corresponding to the three potential sumoylated consensus sites were individually replaced by an arginine (R) (ING2 K72R, ING2 K139R and ING2 K195R). Co-transfection of these mutants with His-SUMO1 followed by a histidine purification shows that the mutants ING2 K72R and ING2 K139R are sumoylated like wild-type (WT) ING2. On the contrary, in accordance with the result obtained with the truncated form of ING2, the ING2 K195R mutant is not sumoylated (Figure 2c ). This result indicates that ING2 is mainly sumoylated on the K195 residue.
Mutation of lysine 195 prevents not only ING2 sumoylation but also other potential post-translational modifications such as ubiquitination or acetylation. Thus, we generated a mutant of ING2 within the consensus sequence by changing the glutamic acid 197 into an alanine (ING2 E197A). Such mutation is reported to disrupt sumoylation by affecting the interaction of the substrate with the SUMO-conjugating enzyme Ubc9 (Bernier-Villamor et al., 2002) . Consequently, this mutant may be post-translationally modified on K195 but not sumoylated. As a matter of fact, co-transfection of the ING2 E197A mutant with His-SUMO1 followed by histidine purification shows that ING2 E197A cannot be sumoylated (Figure 2d ). Subcellular localization of ING2 is independent on sumoylation Initially, SUMO modifications have been reported to regulate protein subcellular localization. Indeed, Ran-GAP sumoylation was shown to regulate its targeting to nuclear pore complexes (Matunis et al., 1996) . As the sumoylated residue K195 is found within the nuclear localization signal, we hypothesized that ING2 sumoylation may be involved in its subcellular localization. Figure 3a) . Thus, ING2 sumoylation on lysine 195 is not involved in its nuclear targeting. Furthermore, as ING2 has been reported to bind to the chromatin, we hypothesized that ING2 sumoylation may be involved in its targeting to the chromatin (Shi et al., 2006) . To test this hypothesis we performed chromatin-enriched fraction (CEF) isolation in cells overexpressing ING2, ING2 K195R or ING2 E197A. This experiment shows that the same amount of protein is present in the CEF for all the constructs (Figure 3b ). Taken together, these results suggest that sumoylation of ING2 is not required for the targeting of ING2 to the nucleus or to the chromatin.
ING2 sumoylation on residue K195 enhances its binding to the Sin3A complex As we initially identified ING2 sumoylation in the Sin3A complex, we hypothesized that ING2 binding to the Sin3A complex may be regulated by its sumoylation. To test this hypothesis, we performed Sin3A immunoprecipitation (IP) in U2OS cells co-transfected with a siRNA targeting the 3 0 -untranslated region (UTR) of ING2 mRNA (to suppress ING2 endogenous expression) and plasmids expressing either ING2 WT, ING2 K195R or ING2 E297A. WT ING2 co-immunoprecipitates (co-IP) with Sin3A whereas, strikingly, both ING2 K195R and ING2 E197A co-IP more weakly with Sin3A ( Figure 4a ). This result suggests that sumoylation of ING2 enhances its association with Sin3a. However, the decreased affinity observed between ING2 mutants and Sin3A could also be because of the mutation being present in the domain of ING2 necessary for the physical interaction with Sin3A. Consequently, we determined which region of ING2 is involved in its binding to Sin3A (Figures 4b and c) . Sin3A IP in U2OS cells overexpressing ING2-truncated forms, ING2 DN140 and ING2 DN240, shows that ING2 DN240, but not the ING2 DN140, co-IP with Sin3A (Figures 4b and c) . This result indicates that, as previously described for p33ING1b (Skowyra et al., 2001) , the region of ING2 protein responsible for the association with the Sin3A complex is located between the amino acid 40 and 140. 
Sumoylation of ING2 regulates gene expression
Accumulating evidences have involved ING2 in the regulation of gene expression. Indeed, one study has shown that in response to the stress induced by doxorubicin, exogenously expressed ING2 recruits the Sin3A/HDAC complex to the promoter of cyclin D1 and c-myc to repress their expression (Shi et al., 2006) . Another study has identified eight genes that are upregulated after ING2 overexpression (Feng et al., 2006) . However, in these two studies, genes regulated by ING2 were identified after a stress or under nonphysiological conditions. Thus, to identify genes that are regulated by ING2 in normal cell growth conditions, we inhibited ING2 expression by transfection of a siRNA targeting ING2 (siING2) into two different cell lines (U2OS and RKO) and we analyzed gene expression by microarrays (Supplementary Tables 2 and 3 ). This experiment allowed the identification of seven genes strongly downregulated after ING2 silencing in both U2OS and RKO cell lines (Figure 5a and Supplementary Table 4 ). Using quantitative real-time PCR the expression fold change of these seven genes after ING2 downregulation was confirmed (Figure 5c ), whereas the efficiency of ING2 downregulation was verified by western blot (Figure 5b ). Among these genes, SPP1 (secreted phosphoprotein 1) and TMEM71 (transmembrane protein 71) are most strongly affected by ING2 repression. Thus, to determine whether these two genes are directly regulated by ING2, we assessed the presence of ING2 on their promoter region by chromatin immunoprecipitation (ChIP) followed by PCR analysis (Figure 5d and Supplementary Figure 2a) . This experiment shows that ING2 is present on SPP1 and TMEM71 promoters in siCT-transfected cells, but not in siING2-transfected cells. This indicates that the regulation of these two genes may be directly mediated by ING2. As many studies have reported that sumoylation of proteins can regulate their transcriptional activities, we hypothesized that ING2 sumoylation could be involved in the regulation of its targeted genes. have a significantly lower expression in cells overexpressing ING2 E197A when compared with WT ING2, indicating that their expression is dependent on ING2 sumoylation (Figure 5f and Supplementary Figure 2c) . On the contrary, CMKOR1, SLC26A4 and DUSP19 have the same level of expression in cells expressing both WT ING2 and ING2 E197A, suggesting that in these conditions ING2 sumoylation is not involved in their regulation (Figure 5f ). Overall, these results show that ING2 directly regulates the expression of several genes and that the regulation of a subset of these genes also requires the sumoylation of ING2.
ING2 sumoylation and Sin3a mediate gene expression
As we have shown that the sumoylation of ING2 enhances its association with Sin3A and is required for the mediation of gene expression, we hypothesized that ING2 sumoylation, in association with Sin3A, could mediate gene expression. To address this question, we further analyzed the regulation of TMEM71 gene whose expression appeared to be the most dependent on ING2 sumoylation (Figure 5f ). In the first step, we analyzed the expression level of TMEM71 in cells transfected with either a siCT or a siRNA directed against Sin3A (siSin3A). The efficiency of Sin3A downregulation was analyzed by western blot (Figure 6a ), and quantitative real-time PCR analysis showed a strong reduction of TMEM71 expression in siSin3A-transfected cells when compared with control ( Figure 6b ). This result indicates that TMEM71 expression is also dependent on Sin3A. To gain further insights into the mechanism of TMEM71 regulation by Sin3A and its relationship with ING2, we performed a Sin3A ChIP on siCT-or siING2-transfected cells. PCR analysis of ChIP products (Figure 6c and Supplementary Figure 3) shows that Sin3A is present on the promoter of TMEM71 in siCT cells but not in siING2 cells, indicating that the regulation of TMEM71 expression by Sin3A may be direct and that its presence on this promoter is dependent on ING2. To further determine whether ING2 sumoylation is involved in this process, we performed another ChIP experiment of ING2 or Sin3A in cells co-transfected with siING2 3 0 UTR and WT ING2 or ING2 E197A. PCR analysis of these ChIPs shows that Sin3A targeting on this promoter required ING2 sumoylation and that ING2 itself needs to be sumoylated to bind to TMEM71 promoter (Figure 6c) . Altogether, these results show that both ING2 and Sin3A are present on TMEM71 promoter in an ING2 sumoylation-dependent manner to mediate the expression of this gene. would also act as a caretaker tumor-suppressor protein to prevent tumorigenesis and all ING proteins could have a role in the replication process (Larrieu and Pedeux, 2009 ). However, how ING2 itself is regulated is unknown.
In this study, we show that ING2 can be posttranslationally modified by SUMO1 on lysine 195 (K195), both in vitro and in vivo. This residue is found within the sumoylation consensus motif A194KQE197. Thus, it is the first time that a post-translational modification of ING2 is reported. Bioinformatic analysis of the amino acid sequence of the other members of the ING proteins family with the SumoPlot online software shows the presence of several sumoylation consensus sequences. This suggests that all ING proteins could also be subjected to sumoylation. Thus, our findings provide new insights into how INGs could be regulated.
Interestingly, the sumoylated consensus site that we identified on ING2 is found within a PDSM (phosphorylation-dependent sumoylation motif). Such domain has recently been described and is composed of a sumoylation consensus site followed two or three amino acids further, by a serine and a proline (cKxExxSP) (Hietakangas et al., 2006) . In this study the authors show that the phosphorylation of the serine can regulate the sumoylation of the juxtaposed sumoylation consensus site. The potential PDSM of ING2 (A194KQER-EASP202) is conserved on p33ING1b (A192KAER EASP200), suggesting that p33ING1b could also be sumoylated. p33ING1b has been reported to be phosphorylated on serine 199 (S199) to regulate its amount in the nucleus. Indeed, this phosphorylation event was shown to be required for p33ING1 binding to the 14-3-3Z cargo protein in order to be exported from the nucleus (Gong et al., 2006) . Interestingly, the serine 199 of ING1 is the serine residue belonging to the potential PDSM. As the potential PDSMs of ING2 and p33ING1b are sumoylated or phosphorylated, respectively, this strongly suggests that ING2 sumoylation could be regulated by an adjacent phosphorylation site and, reciprocally, that ING1 phosphorylation could regulate its potential sumoylation. Gong et al. (2006) observed p33ING1b exportation from the nucleus after 14-3-3Z overexpression. Thus, even if under our experimental conditions we observed that ING2 subcellular localization is independent on its sumoylation, we cannot exclude that in other conditions sumoylation of ING2 could be involved in this process.
As we initially hypothesized that ING2 could be sumoylated in the Sin3A complex, we investigated the role of ING2 sumoylation for its association with Sin3A. We show that ING2 sumoylation enhances its association with Sin3A. Sin3A is a stable component of the Sin3A/HDAC chromatin-modifying complex and is thus involved not only in the repression but also in the activation of a large number of genes (Dannenberg et al., 2005; Farhana et al., 2009 ). ING2 and Sin3A were previously shown to associate to regulate gene expressions (Shi et al., 2006) . Therefore, we investigated the role of ING2 sumoylation in this process. We found that among seven genes identified as regulated by ING2 (SPP1, TMEM71, LY96, H6PD, CMKOR1, SLC26A4 and DUSP19), four of them (SPP1, TMEM71, LY96 and H6PD) were also dependent on ING2 sumoylation. We also show that this regulation can occur directly via the recruitment of ING2 and Sin3A on the promoter of genes in a sumoylation-dependent manner. Interestingly, some of these genes have been associated with cellular processes in which ING2 is known to be involved. It is the case for the SPP1 gene that has been shown to be an effector of p53 that is upregulated by p53 in response to DNA damage (Morimoto et al., 2002) . As ING2 has been previously described as being able to activate p53 in response to DNA damage, it could be interesting to investigate the potential link between the decrease in SPP1 observed after ING2 dowregulation and the activation of p53. Moreover, in addition to the genes identified in this study, it would be (c) PCR products of ChIP analysis performed with rat monoclonal ING2 or mouse monoclonal Sin3A antibodies in cells transfected or co-transfected with siRNA and plasmids when indicated, using specific primers for the TMEM71 promoter. Input corresponds to 2% of cell lysates used for ChIP, and rat or mouse IgGs were used as control of ChIP specificity. PCR product signals were quantified using ImageJ.
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interesting to determine whether ING2 sumoylation could be involved in the regulation of the genes that were previously identified in response to genotoxic stress (Shi et al., 2006) or after overexpression of ING2 (Feng et al., 2006) . This would help determining in which condition ING2 is sumoylated and how this sumoylation is regulated.
As we show that ING2 sumoylation enhances its association with Sin3A, it is then possible that it can also regulate its association with other protein partners. For example, we have recently identified that ING2 can interact with the DNA replication elongation protein PCNA (proliferating cell nuclear antigen) to regulate normal DNA replication . Thus, it would be interesting to investigate the role of ING2 sumoylation in this process. Further investigations on the sumoylation of other ING proteins could provide information on how their association with their known partners such as histone acetyltransferase and HDAC complexes could be regulated. Overall, this study highlights the first mechanism of ING2 post-translational regulation by sumoylation to regulate gene expression mediated by Sin3A and thus provides new insights into how ING proteins could be regulated.
Materials and methods

Cell culture
The colon carcinoma cell line, RKO, and the osteosarcoma cell line, U2OS, were maintained in Dulbecco's modified Eagle's medium and McCoy's 5A medium, respectively, supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 Ag/ ml streptomycin. Cells were incubated at 37 1C in a humidified atmosphere of 5% CO 2 .
Plasmid construction, siRNA and transfections The truncated ING2 sequences, ING2 DC165, ING2 DC204, ING2 DN240 and ING2 DN140, were generated with PCR from pcDNA3.1-ING2 (Nagashima et al., 2001) and 5 0 -AGGGUAAAUGCAUAAGACUAUGCAAUAAU-3 0 , respectively. For the control (siCT), the universal stealth siRNA negative control (Invitrogen) was used.
Plasmids were transfected using Lipofectamine reagent in combination with PLUS Reagent (Invitrogen) according to the manufacturer's instructions. Stealth siRNAs were transfected using Lipofectamine RNAimax (Invitrogen) according to the manufacturer's instructions. Plasmids and stealth siRNA were co-transfected using Lipofectamine2000 (Invitrogen) according to the manufacturer's instructions.
Western blot
Protein samples were subjected to electrophoresis using the NuPAGE Novex Bis-Tris Gel Electrophoresis system (Invitrogen). The antibodies used in this study included rabbit polyclonal anti-ING2 (Ping2) (Nagashima et al., 2001) , rat monoclonal anti-ING2 (Gozani et al., 2003) , mouse monoclonal anti-Sin3A (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-b-actin (Invitrogen).
Immunoprecipitation
At 48 h after siRNA transfection or 24 h after plasmid transfection, cells were harvested in IP buffer (50 mM Tris pH 8, 500 mM KCl, 1 mM dithiothreitol, 20% glycerol and 0.1% NP40) containing protease inhibitor cocktail (Roche, Meylan, France) and were subjected to freeze (liquid nitrogen) and thaw (37 1C) three times. Cells extracts were centrifuged at 12 000 g for 10 min and supernatants were recovered. Equal amount of protein extracts were incubated with the Sin3A antibody bound to protein A coupled to agarose beads (Santa Cruz Biotechnology) for 4 h with rocking at 4 1C. Agarose beads were washed four times with IP buffer. Immunoprecipitated samples were analyzed by western blotting.
Histidine purification
At 24 h after plasmid transfection, cells were harvested and subjected to histidine purification under denaturing conditions using the ProBondTM Purification System (Invitrogen) according to the manufacturer's instructions. The purified extracts were analyzed by western blotting
CEF isolation
At 24 h after plasmid transfections, cells were harvested and their nuclei were isolated using the Nuclear and Cytoplasmic Extraction Reagent kit (NE-PER; Pierce, Rockford, IL, USA) according to the manufacturer's instructions. The CEF was then isolated by resuspending cell nuclei in ice-cold hypotonic buffer (3 mM EDTA, 0.2 mM EGTA and 1 mM dithiothreitol, pH 7.8) containing protease inhibitor cocktail (Roche). After centrifugation at 1700 g for 5 min, the soluble fraction (supernatant) was removed and the CEF (pellet) was washed twice with the hypotonic buffer. The CEF was then resuspended by sonication in sonication buffer (10 mM Tris pH 7.4, 10 mM MgCl 2 and 10% sucrose) containing protease inhibitor cocktail (Roche, no. 362). Same protein amounts of CEF were analyzed by western blotting.
